This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slipped 4.1% to $1.39 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.1% to 20,630.66 and the Dow Jones Industrial Average rising 0.4% to 44,650.64.
The stock's fall snapped a two-day winning streak.
Inovio Pharmaceuticals Inc. closed 88.7% short of its 52-week high of $12.33, which the company achieved on July 26th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.9% to $157.69, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.86% to $25.78.
Trading volume totaled 2.6 million, compared to the 50-day average of 1.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 10, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.